J P Kostrzewa
Overview
Explore the profile of J P Kostrzewa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
66
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kostrzewa R, Kostrzewa J, Kostrzewa R, Nowak P, Brus R
J Neural Transm (Vienna)
. 2007 Nov;
115(2):287-98.
PMID: 17994186
For more than 50 years, heavy metal exposure during pre- or post-natal ontogeny has been known to produce long-lived hyperactivity in rodents. Global brain injury produced by neonatal hypoxia also...
2.
Kostrzewa R, Kostrzewa J, Brus R, Kostrzewa R, Nowak P
J Neural Transm Suppl
. 2006 Oct;
(70):277-9.
PMID: 17017542
Rats lesioned shortly after birth with 6-hydroxydopamine are posed as a near-ideal model of severe Parkinson's disease, because of the non-lethality of the procedure, near-total destruction of nigrostriatal dopaminergic fibers,...
3.
Kostrzewa R, Nowak P, Kostrzewa J, Kostrzewa R, Brus R
Amino Acids
. 2005 Mar;
28(2):157-64.
PMID: 15750845
L-Dihydroxyphenylalanine (L: -DOPA), the anti-parkinsonian drug affording the greatest symptomatic relief of parkinsonian symptoms, is still misunderstood in terms of its neurotoxic potential and the mechanism by which generated dopamine...
4.
Kostrzewa R, Kostrzewa J, Brus R
Amino Acids
. 2002 Oct;
23(1-3):57-63.
PMID: 12373519
Despite its being the most efficacious drug for symptom reversal in Parkinson's disease (PD), there is concern that chronic levodopa (L-DOPA) treatment may be detrimental. In this paper we review...
5.
Kostrzewa R, Brus R, Kostrzewa J
Pol J Pharmacol
. 2002 Jan;
53(2):165-6.
PMID: 11787956
No abstract available.
6.
Kostrzewa R, Kostrzewa J, Brus R
Amino Acids
. 2000 Oct;
19(1):183-99.
PMID: 11026489
To determine if greater amounts of hydroxyl radical (*OH) are formed by dopamine (DA) denervation and treatment with L-dihydroxyphenylalanine (L-DOPA), the neostriatum was DA denervated (99% reduction in DA content)...